We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
+11.29%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.06B
AUM Growth
+$40.2M
(+3.9%)
Cap. Flow
-$31.9M
Cap. Flow
% of AUM
-3%
Top 10 Holdings %
Top 10 Hldgs %
38.82%
Holding
432
New
78
Increased
76
Reduced
169
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Diamondback Energy
FANG
|
+$61.4M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$26.6M |
| 3 |
Ovintiv
OVV
|
+$10M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$5.48M |
| 5 |
CHX
ChampionX
CHX
|
+$3.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DEN
Denbury Inc.
DEN
|
+$25.7M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$17.9M |
| 3 |
Antero Resources
AR
|
+$13.6M |
| 4 |
Accenture
ACN
|
+$10.7M |
| 5 |
Home Depot
HD
|
+$8.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 37.03% |
| 2 | Healthcare | 10.56% |
| 3 | Technology | 9.98% |
| 4 | Financials | 9.12% |
| 5 | Consumer Discretionary | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
AdaptHealth
AHCO
$1.46B
| $482K | 0.05% |
25,057
-9,941
| -28% | -$210K |
|
252
AEON Biopharma
AEON
$11.1M
| $479K | 0.05% |
662
| – | – |
|
253
Gladstone Capital
GLAD
$425M
| $478K | 0.04% |
24,822
| – | – |
|
254
Kiniksa Pharmaceuticals
KNSA
$4.83B
| $477K | 0.04% |
+31,874
| New | +$464K |
|
255
Geron
GERN
$911M
| $477K | 0.04% |
197,024
| – | – |
|
256
Alphatec Holdings
ATEC
$1.27B
| $459K | 0.04% |
+37,157
| New | +$374K |
|
257
Zeta Global
ZETA
$4.77B
| $457K | 0.04% |
+55,997
| New | +$454K |
|
258
LoveSac
LOVE
$239M
| $456K | 0.04% |
20,697
-6,419
| -24% | -$144K |
|
259
Ambarella
AMBA
$2.99B
| $455K | 0.04% |
+5,538
| New | +$369K |
|
260
Consensus Cloud Solutions
CCSI
$669M
| $452K | 0.04% |
+8,410
| New | +$458K |
|
261
ADT
ADT
$5.16B
| $442K | 0.04% |
48,744
+23,319
| +92% | +$207K |
|
262
Destination XL Group
DXLG
$34.7M
| $441K | 0.04% |
+65,345
| New | +$419K |
|
263
Aehr Test Systems
AEHR
$2.48B
| $441K | 0.04% |
+21,926
| New | +$469K |
|
|
HDSN
264
Hudson Technologies
HDSN
$267M
| $439K | 0.04% |
+43,342
| New | +$424K |
|
265
Victory Capital Holdings
VCTR
$6.08B
| $438K | 0.04% |
+16,334
| New | +$459K |
|
266
Prothena Corp
PRTA
$458M
| $429K | 0.04% |
+7,120
| New | +$417K |
|
267
Suburban Propane Partners
SPH
$1.23B
| $404K | 0.04% |
26,625
+31
| +0.1% | +$496 |
|
268
AbCellera Biologics
ABCL
$1.62B
| $404K | 0.04% |
39,843
-37,839
| -49% | -$437K |
|
269
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
| $402K | 0.04% |
8,065
| – | – |
|
270
Knight Transportation
KNX
$11.8B
| $398K | 0.04% |
7,600
-4,506
| -37% | -$233K |
|
271
PDF Solutions
PDFS
$2.13B
| $396K | 0.04% |
+13,871
| New | +$375K |
|
272
Aaon
AAON
$8.41B
| $395K | 0.04% |
+7,869
| New | +$367K |
|
273
Spire
SR
$4.92B
| $393K | 0.04% |
5,709
-5
| -0.1% | -$340 |
|
274
Nu Skin
NUS
$247M
| $391K | 0.04% |
+9,267
| New | +$357K |
|
275
Celsius Holdings
CELH
$6.93B
| $387K | 0.04% |
+11,163
| New | +$364K |
|
Similar funds
VFG
SLG
KCP
UAG
PS
CICI
RPAM
BBI
Advisory Research's Q4 2022 Portfolio in Review
As of Q4 2022, Advisory Research held 432 positions worth $1.06B, up 3.9% from $1.02B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Advisory Research withdrew a net $31.9M in Q4 2022, closing 68 positions and reducing 169 holdings. Its most notable exit was IAA, Inc. Common Stock, an estimated $6.06M position sold in full.
By sector, the portfolio is most concentrated in Energy at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Advisory Research opened a new position in iShares Russell 2000 ETF worth $5.37M.
- Advisory Research's largest Q4 2022 buy was iShares Russell 2000 ETF: 30,811 shares worth $5.37M.
- Advisory Research added most to Diamondback Energy in Q4 2022, an estimated $61.4M increase.
- Advisory Research's biggest Q4 2022 reduction was Denbury Inc., cutting an estimated $25.7M.
- Advisory Research fully exited IAA, Inc. Common Stock in Q4 2022, selling an estimated $6.06M.
- Advisory Research's ten largest holdings make up 39% of its $1.06B portfolio in Q4 2022.
- Advisory Research opened 78 new positions and closed 68 in Q4 2022.
- Advisory Research's portfolio value rose 3.9% quarter-over-quarter to $1.06B.
Based on Advisory Research's 13F filing for Q4 2022, filed 13 Feb 2023.